Overview
Speech, language, and cognitive changes in MS reflect underlying disruptions in motor planning and information processing, directly impacting daily communication and functional independence. These domains offer sensitive, low-burden endpoints to monitor disease progression and treatment response in clinical trials.
Why speech matters in Multiple Sclerosis
Speech and language impairments affect up to 40% of people with Multiple Sclerosis, with higher prevalence in those with progressive or long-standing disease. These changes can reduce communicative confidence, limit social engagement, and contribute to emotional distress and reduced quality of life. Redenlab offers digital speech and language assessments that sensitively detect changes in motor and cognitive-linguistic function over time. Our tools enable objective, low-burden monitoring to support clinical decision-making and enhance endpoint sensitivity in MS trials.
Enhanced speech analysis for MS trials
Purpose-built speech algorithms for MS
Validated digital endpoints
Leaders in neurological speech analytics
Large MS-specific datasets
Remote and multilingual capability
Redenlab’s Multiple Sclerosis experience
Redenlab partnered with the Alfred Hospital and Monash University to run two large longitudinal clinical tracking studies in MS. This work was in-part sponsored by pharmaceutical industry partners based in Switzerland.
